ELAN
Elanco Animal Health
22.10$
+1.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.1% | +16.4% | -1.7% | -13.0% | -1.0% | +17.0% | +4.0% | -8.4% | +0.6% | +19.8% | -0.2% | – | |
| – | +4.3% | -0.9% | -3.4% | -0.2% | +1.0% | +1.0% | +4.2% | -20.2% | +30.9% | -15.6% | -2.7% | – | |
| – | -13.6% | +46.2% | +0.2% | -27.4% | -4.0% | +42.9% | +3.8% | +5.2% | -25.9% | +74.4% | +1.7% | – | |
| – | -8.1% | +10.1% | +2.3% | -2.2% | -6.9% | +16.0% | -2.1% | -3.3% | +4.5% | +4.3% | -5.2% | – | |
| – | -72.8% | +296.5% | +5.0% | -8.8% | -7.1% | +13.7% | +17.3% | -12.3% | -3.7% | +12.7% | +17.8% | – | |
| – | -7.0% | +14.3% | +4.5% | -7.4% | -7.1% | +14.2% | +13.1% | +17.9% | -25.7% | +10.9% | +44.1% | – | |
| – | -76.2% | +1,230.0% | -13.5% | -104.3% | – | +1,412.5% | -29.8% | -68.2% | -29.6% | +1,515.8% | -64.5% | – | |
| – | -6.9% | -1.5% | -1.5% | +30.8% | -27.1% | -14.5% | +32.1% | -25.7% | +75.0% | -37.4% | +3.5% | – | |
| – | – | – | -366.7% | – | -109.1% | – | -58.3% | -300.0% | – | – | -35.6% | – | |
| – | – | -242.9% | – | +983.3% | -122.1% | – | – | -214.3% | – | +76.5% | -93.3% | – | |
| – | – | – | -256.3% | – | -102.2% | – | -83.6% | -409.1% | – | – | -5.3% | – | |
| – | – | +119.8% | -20.1% | +317.4% | -78.5% | +56.6% | -3.6% | -32.6% | -96.6% | +5,166.7% | -13.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.